Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Glycobiology ; 31(10): 1378-1389, 2021 11 18.
Artículo en Inglés | MEDLINE | ID: mdl-34192330

RESUMEN

Leishmania (L.) amazonensis is one of the species responsible for the development of cutaneous leishmaniasis in South America. After entering the vertebrate host, L. (L.) amazonensis invades mainly neutrophils, macrophages and dendritic cells. Studies have shown that gal-3 acts as a pattern recognition receptor. However, the role of this protein in the context of L. (L.) amazonensis infection remains unclear. Here, we investigated the impact of gal-3 expression on experimental infection by L. (L.) amazonensis. Our data showed that gal-3 plays a role in controlling parasite invasion, replication and the formation of endocytic vesicles. Moreover, mice with gal-3 deficiency showed an exacerbated inflammatory response. Taken together, our data shed light to a critical role of gal-3 in the host response to infection by L. (L.) amazonensis.


Asunto(s)
Galectina 3/metabolismo , Leishmania/metabolismo , Leishmaniasis Cutánea/metabolismo , Animales , Femenino , Galectina 3/deficiencia , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados
2.
Microb Pathog ; 135: 103618, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31310832

RESUMEN

P21 is a protein secreted by Trypanosoma cruzi (T. cruzi). Previous studies have shown a spectrum of biological activities performed by P21 such as induction of phagocytosis, leukocyte chemotaxis and inhibition of angiogenesis. However, the activity of P21 in T. cruzi infection remains unknown. Here, we reported the role of P21 in mice harboring late T. cruzi infection. Treatment with recombinant P21 protein (rP21) reduced parasite load and angiogenesis, and induced fibrosis in the cardiac tissue of infected mice. In addition, rP21 reduced the growth of epimastigotes, inhibited intracellular replication of amastigotes and modulated the parasite cell cycle. Our data suggest that P21 controls parasite replication in the host, supporting the survival of both parasite and host.


Asunto(s)
Enfermedad de Chagas/inmunología , Proteínas Protozoarias/inmunología , Proteínas Protozoarias/metabolismo , Trypanosoma cruzi/inmunología , Trypanosoma cruzi/fisiología , Animales , Anticuerpos Antiprotozoarios/inmunología , Antígenos de Protozoos/inmunología , Ciclo Celular , Enfermedad de Chagas/parasitología , Enfermedad de Chagas/patología , Modelos Animales de Enfermedad , Fibrosis , Corazón , Interacciones Huésped-Parásitos , Ratones , Ratones Endogámicos BALB C , Carga de Parásitos , Proteínas Protozoarias/genética , Proteínas Recombinantes , Trypanosoma cruzi/genética , Trypanosoma cruzi/patogenicidad
3.
ACS Omega ; 5(3): 1363-1370, 2020 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-32010806

RESUMEN

Scheelea phalerata Mart. ex Spreng (Arecaceae) is a palm tree found in the Brazilian cerrado. There are no topics related to volatile oils from S. phalerata leaves in the literature. This work determines its chemical composition and evaluates the biological activity under two different seasonal conditions (dry and rainy seasons). The dry essential oil yield was 0.034 ± 0.001% and the rainy essential oil yield was 0.011 ± 0.003%. Both essential oils presented different qualitative and quantitative compositions (99.4 and 98.5%). The main constituents of the dry essential oil were phytol (36.7%), nonadecane (9.7%), linolenic acid (9.1%), (Z)-hex-3-en-1-ol (4.2%), and squalene (4.0%). The main constituents of the rainy essential oil were phytol (26.1%), palmitic acid (18.7%), hexan-1-ol (15.6%), (Z)-hex-3-en-1-ol (9.7%), and oleic acid (4.0%). The antileishmanial activity against promastigotes of Leishmania amazonensis was observed only for the rainy season essential oil (IC50 value of 165.05 ± 33.26 µg mL-1). A molecular docking study showed that alcohols exert a paramount efficacy and that the action of some essential oil compounds may be similar to that of amphotericin B. Still, only the essential oil from the dry season showed moderate antibacterial activity against S. sanguinis (MICs 200-400 µg mL-1). The cytotoxicity against Vero cells was identical (>512) for both essential oils. The novel data here for both chemical characterization and biological activity, in particular, evidence that the action of these compounds is similar to that of amphotericin B, provide valuable information to the drug-discovery field.

4.
J Pharm Pharmacol ; 70(11): 1541-1552, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30136729

RESUMEN

OBJECTIVES: This work aimed to evaluate the antifungal and cytotoxic activity of the EtOH extract and fractions of Banisteriopsis argyrophylla leaves, and to perform the identification of these bioactive metabolites. METHODS: The EtOAc fraction (EAF) obtained from the ethanolic extract of B. argyrophylla leaves showed better antifungal potential against Candida spp. In this fraction, ten flavonoids have been identified by UHPLC-ESI-MSn . Then, EAF was submitted to column chromatography to give four new fractions (A1-A4). The cytotoxicity was determined against Vero cells. KEY FINDINGS: The EAF showed better antifungal potential against Candida spp. with minimum inhibitory concentrations (MICs) between 31.25 and 93.75 µg/ml. The (-)-catechin (fraction A1) showed a MIC of 2.83 µg/ml against Candida glabrata. Fractions A2, A3 and A4 were rich in quercetins and kaempferols and showed good inhibitory concentrations (5.86-46.87 µg/ml) against C. albicans, C. glabrata and C. tropicalis. CONCLUSIONS: The EtOH extract, fractions and the isolated (-)-catechin showed lower toxicity to Vero cells than cisplatin, used as a positive control. Thus, the leaves of B. argyrophylla are a promising source of antifungal agents.


Asunto(s)
Antifúngicos/farmacología , Banisteriopsis , Candida/efectos de los fármacos , Extractos Vegetales/farmacología , Hojas de la Planta , Animales , Antifúngicos/aislamiento & purificación , Antifúngicos/toxicidad , Banisteriopsis/química , Candida/clasificación , Candida/crecimiento & desarrollo , Supervivencia Celular/efectos de los fármacos , Chlorocebus aethiops , Relación Dosis-Respuesta a Droga , Pruebas de Sensibilidad Microbiana , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/toxicidad , Hojas de la Planta/química , Células Vero
5.
Artículo en Inglés | MEDLINE | ID: mdl-29164071

RESUMEN

Trypanosoma cruzi interacts with host cells, including cardiomyocytes, and induces the production of cytokines, chemokines, metalloproteinases, and glycan-binding proteins. Among the glycan-binding proteins is Galectin-3 (Gal-3), which is upregulated after T. cruzi infection. Gal-3 is a member of the lectin family with affinity for ß-galactose containing molecules; it can be found in both the nucleus and the cytoplasm and can be either membrane-associated or secreted. This lectin is involved in several immunoregulatory and parasite infection process. Here, we explored the consequences of Gal-3 deficiency during acute and chronic T. cruzi experimental infection. Our results demonstrated that lack of Gal-3 enhanced in vitro replication of intracellular parasites, increased in vivo systemic parasitaemia, and reduced leukocyte recruitment. Moreover, we observed decreased secretion of pro-inflammatory cytokines in spleen and heart of infected Gal-3 knockout mice. Lack of Gal-3 also led to elevated mast cell recruitment and fibrosis of heart tissue. In conclusion, galectin-3 expression plays a pivotal role in controlling T. cruzi infection, preventing heart damage and fibrosis.


Asunto(s)
Enfermedad de Chagas/inmunología , Enfermedad de Chagas/patología , Galectina 3/inmunología , Galectina 3/metabolismo , Inmunidad Innata/inmunología , Trypanosoma cruzi/inmunología , Animales , Supervivencia Celular , Enfermedad de Chagas/parasitología , Chlorocebus aethiops , Colágeno/análisis , Citocinas/metabolismo , Modelos Animales de Enfermedad , Fibrosis/inmunología , Fibrosis/prevención & control , Galactósidos , Galectina 3/genética , Corazón , Interacciones Huésped-Parásitos , Macrófagos Peritoneales/parasitología , Masculino , Mastocitos , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Parasitemia , Bazo/inmunología , Trypanosoma cruzi/patogenicidad , Células Vero
6.
Sci Rep ; 7(1): 7077, 2017 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-28765552

RESUMEN

Phospholipases A2 (PLA2s) overexpression is closely associated with the malignant potential of breast cancers. Here, we showed for the first the antitumoral effects of γCdcPLI, a PLA2 inhibitor from Crotalus durissus collilineatus via PI3K/Akt pathway on MDA-MB-231 cell. Firstly, γCdcPLI was more cytotoxic to MDA-MB-231 breast cancer cells than other cell lines (MCF-7, HeLa, PC3 and A549) and did not affect the viability of non-tumorigenic breast cell (MCF 10A). In addition, γCdcPLI induced modulation of important mediators of apoptosis pathways such as p53, MAPK-ERK, BIRC5 and MDM2. γCdcPLI decreased MDA-MB-231 adhesion, migration and invasion. Interestingly, the γCdcPLI also inhibited the adhesion and migration of endothelial cells and blocked angiogenesis by inhibiting tube formation by HUVECs in vitro and sprouting elongation on aortic ring assay ex vivo. Furthermore, γCdcPLI reduced the production of vascular endothelial growth factor (VEGF). γCdcPLI was also able to decrease PGE2 levels in MDA-MB-231 and inhibited gene and protein expression of the PI3K/Akt pathway. In conclusion, γCdcPLI showed in vitro antitumoral, antimestatatic and anti-angiogenic potential effects and could be an attractive approach for futures studies in cancer therapy.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias de la Mama , Lipoproteínas/farmacología , Proteína Oncogénica v-akt/metabolismo , Fosfatidilinositol 3-Quinasa/metabolismo , Inhibidores de Fosfolipasa A2/farmacología , Antineoplásicos/aislamiento & purificación , Adhesión Celular/efectos de los fármacos , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Venenos de Crotálidos/química , Células Endoteliales/efectos de los fármacos , Humanos , Lipoproteínas/aislamiento & purificación , Modelos Biológicos , Neovascularización Patológica , Inhibidores de Fosfolipasa A2/aislamiento & purificación
7.
Acta Trop ; 157: 42-53, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26827742

RESUMEN

Trypanosoma cruzi has high biological and biochemical diversity and variable tissue tropism. Here we aimed to verify the kinetics of cytokine and chemokine in situ secretion in animals infected with two distinct T. cruzi strains after oral inoculation. Also, we investigated parasite migration, residence and pathological damage in stomach, heart and spleen. Our results showed that host immune response against T. cruzi infection is an intricate phenomenon that depends on the parasite strain, on the infected organ and on the time point of the infection. We believe that a wide comprehension of host immune response will potentially provide basis for the development of immunotherapeutic strategies in order to clear parasitism and minimize tissue injury. In this context, we find that KC poses as a possible tool to be used.


Asunto(s)
Enfermedad de Chagas/inmunología , Enfermedad de Chagas/parasitología , Quimiocinas/metabolismo , Citocinas/metabolismo , Antígenos de Histocompatibilidad Clase II/metabolismo , Trypanosoma cruzi/inmunología , Animales , Enfermedad de Chagas/veterinaria , Femenino , Corazón/parasitología , Ratones , ARN Mensajero/metabolismo , Bazo/parasitología , Estómago/parasitología
8.
Pathog Glob Health ; 108(1): 30-6, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24548158

RESUMEN

The aim of the present study was to evaluate the effects of crude extracts from Handroanthus impetiginosa, Ageratum conyzoides, and Ruta graveolens on Leishmania amazonensis and Trypanosoma cruzi infection in vitro. The results showed that the extracts caused significant toxicity in promastigotes and trypomastigotes. A significant decrease in the rate of cell invasion by pretreated trypomastigotes and promastigotes was also observed. The extracts caused a significant reduction of the multiplication of intracellular amastigotes of both parasites. Therefore, these herbal extracts may be potential candidates for the development of drugs for the treatment of leishmaniasis and Chagas disease.


Asunto(s)
Antígenos de Protozoos/efectos de los fármacos , Antiprotozoarios/farmacología , Enfermedad de Chagas/tratamiento farmacológico , Leishmania/efectos de los fármacos , Leishmaniasis/tratamiento farmacológico , Fitoterapia/métodos , Preparaciones de Plantas/farmacología , Trypanosoma cruzi/efectos de los fármacos , Animales , Antígenos de Superficie/efectos de los fármacos , Asteraceae/química , Bignoniaceae/química , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Masculino , Neuraminidasa/efectos de los fármacos , Proteínas Protozoarias/efectos de los fármacos , Rutaceae/química , Tripanosomiasis/tratamiento farmacológico , Glicoproteínas Variantes de Superficie de Trypanosoma/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA